These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12100104)

  • 1. Factors in making the decision to forgo conventional cancer treatment.
    Verhoef MJ; White MA
    Cancer Pract; 2002; 10(4):201-7. PubMed ID: 12100104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
    Shumay DM; Maskarinec G; Kakai H; Gotay CC;
    J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.
    Tatsumura Y; Maskarinec G; Shumay DM; Kakai H
    Altern Ther Health Med; 2003; 9(3):64-71. PubMed ID: 12776477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why people choose to not use complementary therapies during cancer treatment: a focus group study.
    Beatty L; Koczwara B; Knott V; Wade T
    Eur J Cancer Care (Engl); 2012 Jan; 21(1):98-106. PubMed ID: 21848581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?
    Smith PJ; Clavarino A; Long J; Steadman KJ
    Asia Pac J Clin Oncol; 2014 Mar; 10(1):1-10. PubMed ID: 23910177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
    Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
    Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine.
    White M; Verhoef M
    Integr Cancer Ther; 2006 Jun; 5(2):117-22. PubMed ID: 16685076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
    Salamonsen A
    Eur J Public Health; 2016 Apr; 26(2):225-9. PubMed ID: 26450914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment decision making experiences of migrant cancer patients and their families in Australia.
    Shaw J; Zou X; Butow P
    Patient Educ Couns; 2015 Jun; 98(6):742-7. PubMed ID: 25770050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary therapies and cancer care: an overview.
    Verhoef MJ; Hilsden RJ; O'Beirne M
    Patient Educ Couns; 1999 Oct; 38(2):93-100. PubMed ID: 14528701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use.
    Boon H; Brown JB; Gavin A; Kennard MA; Stewart M
    Qual Health Res; 1999 Sep; 9(5):639-53. PubMed ID: 10558372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a model of decision-making about complementary therapy use for patients with cancer: a qualitative study.
    Evans M; Sharp D; Shaw A
    Patient Educ Couns; 2012 Dec; 89(3):374-80. PubMed ID: 22195598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies.
    Citrin DL; Bloom DL; Grutsch JF; Mortensen SJ; Lis CG
    Oncologist; 2012; 17(5):607-12. PubMed ID: 22531358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative care. Patient choices for adjunct therapies within a cancer center.
    Coss RA; McGrath P; Caggiano V
    Cancer Pract; 1998; 6(3):176-81. PubMed ID: 9652249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Men with prostate cancer: making decisions about complementary/alternative medicine.
    Boon H; Brown JB; Gavin A; Westlake K
    Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making control: why men decline treatment for prostate cancer.
    White MA; Verhoef MJ
    Integr Cancer Ther; 2003 Sep; 2(3):217-24. PubMed ID: 15035883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the conventional to the alternative: exploring patients' pathways of cancer treatment and care.
    Mulkins AL; McKenzie E; Balneaves LG; Salamonsen A; Verhoef MJ
    J Complement Integr Med; 2016 Mar; 13(1):51-64. PubMed ID: 26259233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The decision-making journey of malaysian women with early breast cancer: a qualitative study.
    Abdullah A; Abdullah KL; Yip CH; Teo SH; Taib NA; Ng CJ
    Asian Pac J Cancer Prev; 2013; 14(12):7143-7. PubMed ID: 24460266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.